M. Oikawa
Papers
1
Total Citations
13
H-Index
1
About
M. Oikawa is a urologic oncologist whose research focuses on optimizing treatment strategies for high-risk prostate cancer, particularly through the integration of neoadjuvant therapies and minimally invasive surgical techniques. Their most cited work, a 2018 study comparing robot-assisted and minimum incision endoscopic radical prostatectomy following neoadjuvant chemohormonal therapy, has garnered 13 citations and provides critical insights into perioperative and oncological outcomes. Oikawa’s contributions lie in demonstrating the feasibility and safety of combining aggressive systemic therapy with advanced surgical approaches, aiming to improve outcomes for patients with aggressive disease. By evaluating both robotic and endoscopic techniques, their research helps refine surgical decision-making and highlights the potential of multimodal treatment in high-risk settings. This work underscores Oikawa’s commitment to advancing precision in prostate cancer care, bridging the gap between medical and surgical oncology. Their findings offer valuable guidance for clinicians navigating complex cases, making Oikawa a notable figure in the evolving landscape of urologic oncology.
Research Focus
Key Achievements
Top Papers
- 1